Key result
The angiotensin-converting enzyme insertion/deletion polymorphism showed no evidence of association with vascular dementia across 10 pooled studies.
Why the study?
Is the angiotensin-converting enzyme insertion/deletion gene polymorphism associated with an increased risk of vascular dementia?
Meta-Analysis
Is the angiotensin-converting enzyme insertion/deletion gene polymorphism associated with an increased risk of vascular dementia?
The ACE I/D gene polymorphism does not appear to be a significant genetic risk factor for vascular dementia.
Does not support ACE I/D testing for vascular dementia risk; leaves open contributions from other genetic variants.
BACKGROUND: Vascular dementia is the second common cause of dementia, only second to Alzheimer's disease in later life, and has a greater mortality risk than Alzheimer's disease among the elderly population group. The angiotensin-converting enzyme insertion/deletion polymorphism as a risk factor in vascular dementia has been suggested, but direct evidence from genetic association studies remain inconclusive. We performed a meta-analysis pooling data from all relevant studies in order to determine the effect of the insertion/deletion polymorphism on the vascular dementia. METHODS: We applied a random-effects model or fixed-effects model to combine odds ratio and 95% confidence intervals. Q statistic was used to evaluate the homogeneity, and Egger's test and Funnel plot were used to assess publication bias. RESULTS: A total of 10 studies were included worldwide. Publication bias was not observed. There was no evidence of the association of angiotensin-converting enzyme insertion/deletion polymorphism with the vascular dementia in general or in the Asian populations or in the Caucasian populations. CONCLUSIONS: The angiotensin-converting enzyme insertion/deletion polymorphism might be neutral to vascular dementia.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2008) conducted a meta-analysis in Vascular dementia. Angiotensin-converting enzyme insertion/deletion polymorphism was evaluated on Vascular dementia. The angiotensin-converting enzyme insertion/deletion polymorphism showed no evidence of association with vascular dementia across 10 pooled studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: